Back to company

Innosurge Biologics A/S: Financial statements 2023

CVR: 38768964

Innosurge Biologics A/S (CVR 38768964) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,077,814 and a net result of DKK 406,817 compared with DKK 489,687 the year before. That is a decrease of 4.8% compared with the year before. Equity amounted to DKK 1,732,886. The solvency ratio was 36.9%. The company had 2 employees in the financial year.

Gross Profit
2,077,814 kr.
Profit/Loss
406,817 kr.
Equity
1,732,886 kr.
Total Assets
4,696,208 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-2.1 mio.407 t.1.7 mio.2
2022-2.2 mio.490 t.1.3 mio.3
2021-993 t.-613 t.836 t.3
2020--695 t.-2.6 mio.1.4 mio.3
2019-1.2 mio.290 t.2 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Innosurge Biologics A/S appoints new auditorOct 1, 2023

As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Innosurge Biologics A/S.

Auditor steps down at Innosurge Biologics A/SOct 1, 2023

As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Innosurge Biologics A/S.

Innosurge Biologics A/S: The 2022 annual report is outJun 28, 2023

Innosurge Biologics A/S has published its annual report for 2022. Gross profit came to DKK 2,183,245, and the net result was DKK 489,687.

About Innosurge Biologics A/S

Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.

Other financial years